Healthcare Services

A Significant Growth Driver for the Myomectomy Market Is the Effect Of Rising Uterine Disorder Prevalence On Myomectomy Market Growth

April 2, 2026April 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Myomectomy Market By 2030 Starting From Its 2026 Size?

The myomectomy market has experienced significant growth in recent years. It is projected to increase from $1.62 billion in 2025 to $1.76 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.5%. The historical expansion can be attributed to the increasing prevalence of uterine fibroids, a heightened awareness of fertility preservation options, an increase in gynecological surgical procedures, the expansion of hospital surgical infrastructure, and the availability of advanced laparoscopic tools.

The myomectomy market is anticipated to experience substantial growth over the next few years. It is expected to expand to $2.41 billion by 2030, achieving a compound annual growth rate (CAGR) of 8.1%. This expansion during the forecast period is primarily due to factors such as the increasing uptake of robotic gynecologic surgeries, a rise in investments in minimally invasive technologies, a growing need for patient-centric treatment options, the establishment of more specialized women’s health centers, and an increased focus on achieving faster post-surgical recovery. Significant trends projected for this period include the wider adoption of minimally invasive surgical techniques, an increase in the use of robotic-assisted myomectomy procedures, a stronger preference for fertility-preserving treatments, the advancement of sophisticated surgical instrumentation, and an enhanced emphasis on precise surgical outcomes.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20576&type=smp

Which Market Drivers Are Supporting The Expansion Of The Myomectomy Market?

The increasing occurrence of uterine conditions is set to drive the expansion of the myomectomy market. Uterine disorders refer to a spectrum of medical issues affecting the uterus, including fibroids, endometriosis, and uterine cancer, which can manifest as pain, unusual bleeding, and infertility. This rise in prevalence is linked to factors such as enhanced awareness, delayed childbearing, hormonal imbalances, and lifestyle alterations. Myomectomy is employed for uterine disorders to surgically extract fibroids, thereby alleviating symptoms like pain, significant bleeding, and reproductive complications, all while preserving the uterus. As an illustration, in May 2025, data from the Cancer Council Victoria, an Australia-based government organization, indicated that in 2023, 926 women received a diagnosis of uterine cancer, with an incidence rate of 22.3 per 100,000 females. This accounted for 2.4% of all cancers diagnosed and 1.2% of all cancer-related deaths in 2023, establishing uterine cancer as the 5th most commonly diagnosed cancer among females in the region during that year. Therefore, the growing incidence of uterine disorders is a key factor propelling the growth of the myomectomy market.

Which Segment Categories Define The Myomectomy Market?

The myomectomy market covered in this report is segmented –

1) By Surgical Approach: Abdominal Myomectomy, Hysteroscopic Myomectomy, Laparoscopic Myomectomy

2) By Product: Laparoscopic Power Morcellators, Harmonic Scalpel, Laparoscopic Sealer, Other Products

3) By End-User: Hospitals And Clinics, Surgical Centers, Other End-Users

Subsegments:

1) By Abdominal Myomectomy: Open Abdominal Myomectomy (Laparotomy), Mini-Laparotomy Myomectomy

2) By Hysteroscopic Myomectomy: Resectoscopic Myomectomy, Non-Resectoscopic Techniques

3) By Laparoscopic Myomectomy: Conventional Laparoscopic Myomectomy, Robotic-Assisted Laparoscopic Myomectomy

What Trends Are Affecting The Expansion Of The Myomectomy Market?

Major companies operating within the myomectomy market are prioritizing the development of innovative solutions, such as advanced robotic-assisted surgical systems, to cater to the growing demand for minimally invasive procedures, improved surgical precision, and quicker patient recovery. Robotic-assisted systems function as sophisticated surgical platforms that augment the surgeon’s capabilities through high-definition 3D visualization, articulating instruments, and precise motion scaling, offering a notable enhancement compared to traditional open or laparoscopic surgeries. For instance, in March 2023, Intuitive Surgical Inc., a U.S.-based medical technology company, introduced the da Vinci Xi fifth-generation robotic surgical system, an innovative platform engineered to facilitate complex gynecological procedures, including myomectomy. This system integrates enhanced imaging, ergonomically designed controls, and multi-quadrant access, empowering surgeons to execute precise dissections with minimal tissue trauma. Its applications extend to uterine fibroid removal, hysterectomy, and other gynecologic surgeries, offering patients benefits such as reduced post-operative pain, shorter hospital stays, and accelerated recovery.

Who Are The Top Companies Competing In The Myomectomy Market?

Major companies operating in the myomectomy market are Medtronic plc, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc., Smith & Nephew plc, Hologic Inc., CooperSurgical Inc., Teleflex Incorporated, Karl Storz SE & Co. KG, CONMED Corporation, Richard Wolf GmbH, ERBE Elektromedizin GmbH, LiNA Medical ApS, KLS Martin Group, Aspen Surgical, BOWA Medical, Aesculap AG, Mindray Medical International Limited

Read the full myomectomy market report here:

https://www.thebusinessresearchcompany.com/report/myomectomy-global-market-report

How Is The Myomectomy Market Distributed Across Key Geographic Regions?

North America was the largest region in the myomectomy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the myomectomy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Myomectomy Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20576&type=smp

Browse Through More Reports Similar to the Global Myomectomy Market 2026, By The Business Research Company

Myocardial Infarction Global Market Report

https://www.thebusinessresearchcompany.com/report/myocardial-infarction-global-market-report

Cardiometabolic Diseases Global Market Report

https://www.thebusinessresearchcompany.com/report/cardiometabolic-diseases-global-market-report

Heart Attack Diagnostic Global Market Report

https://www.thebusinessresearchcompany.com/report/heart-attack-diagnostic-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795